Monoand bicyclic azole derivatives that inhibit the interaction of ligands with RAGE

Details for Australian Patent Application No. 2003217943 (hide)

Owner TransTech Pharma, Inc.

Inventors Gopalaswamy, Ramesh; Guo, XiaoChuan; Chen, Xin; Hari, Anitha; Avor, Kwasi; Andrews, Robert C; Jones, David R; Mjalli, Adnan M M; Qabaja, Ghassan; Gupta, Suparna

Agent Pizzeys

Pub. Number AU-B-2003217943

PCT Number PCT/US03/06749

PCT Pub. Number WO2003/075921

Priority 60/361,983 05.03.02 US

Filing date 5 March 2003

Wipo publication date 22 September 2003

Acceptance publication date 3 May 2007

International Classifications

A61K 31/4184 (2006.01)

A61K 9/12 (2006.01) Medicinal preparations characterised by special physical form - Aerosols

A61K 31/4164 (2006.01) - 1,3-Diazoles

A61K 31/4178 (2006.01)

A61K 31/42 (2006.01) - Oxazoles

A61K 31/4439 (2006.01)

A61K 31/454 (2006.01)

A61K 31/4725 (2006.01)

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

A61P 15/10 (2006.01) Drugs for genital or sexual disorders

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 27/02 (2006.01) Drugs for disorders of the senses

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 233/54 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 233/64 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 60/361,983 05.03.02 US

30 October 2003 Application Open to Public Inspection

  Published as AU-B-2003217943

23 November 2006 Change of Name(s) of Applicant(s), Section 104

  Transtech Pharma, Inc. The name of the applicant has been changed to TransTech Pharma, Inc.

3 May 2007 Application Accepted

  Published as AU-B-2003217943

30 August 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003217944-METHOD FOR OBTAINING IMPROVED ULTRASONIC BOND STRENGTH

2003217942-MODULATORS OF LEUKOCYTE ACTIVATION, COMPOSITIONS, AND METHODS OF USE